1. An efficient selenium transport pathway of selenoprotein P utilizing a high-affinity ApoER2 receptor variant and being independent of selenocysteine lyase.
- Author
-
Ayako Mizuno, Takashi Toyama, Atsuya Ichikawa, Naoko Sakai, Yuya Yoshioka, Yukina Nishito, Renya Toga, Hiroshi Amesaka, Takayuki Kaneko, Kotoko Arisawa, Ryouhei Tsutsumi, Yuichiro Mita, Shun-ichi Tanaka, Noriko Noguchi, and Yoshiro Saito
- Subjects
- *
SELENOPROTEINS , *SELENIUM , *SELENOCYSTEINE , *PROTEOLYSIS , *APOLIPOPROTEIN E , *BLOOD proteins - Abstract
Selenoprotein P (SeP, encoded by the SELENOP gene) is a plasma protein that contains selenium in the form of selenocysteine residues (Sec, a cysteine analog containing selenium instead of sulfur). SeP functions for the transport of selenium to specific tissues in a receptor-dependent manner. Apolipoprotein E receptor 2 (ApoER2) has been identified as a SeP receptor. However, diverse variants of ApoER2 have been reported, and the details of its tissue specificity and the molecular mechanism of its efficiency remain unclear. In the present study, we found that human T lymphoma Jurkat cells have a high ability to utilize selenium via SeP, while this ability was low in human rhabdomyosarcoma cells. We identified an ApoER2 variant with a high affinity for SeP in Jurkat cells. This variant had a dissociation constant value of 0.67 nM and a highly glycosylated O-linked sugar domain. Moreover, the acidification of intracellular vesicles was necessary for selenium transport via SeP in both cell types. In rhabdomyosarcoma cells, SeP underwent proteolytic degradation in lysosomes and transported selenium in a Sec lyase–dependent manner. However, in Jurkat cells, SeP transported selenium in Sec lyase–independent manner. These findings indicate a preferential selenium transport pathway involving SeP and highaffinity ApoER2 in a Sec lyase–independent manner. Herein, we provide a novel dynamic transport pathway for selenium via SeP. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF